Abstract
Glycosylation, the process of covalently attaching a glycan (mono-, oligo-, or poly-32 saccharide) to an amino acid side chain, is the most prevalent post-translational 33 modification found on proteins, occurring in all domains of life. The attachment of a 34 carbohydrate moiety to certain amino acid side chains in proteins was traditionally 35 thought to be exclusive to eukaryotes and archaea. In the last decade, protein 36 glycosylation, both N-and O-linked, has been increasingly reported in pathogenic bacteria 37 such as well as commensal bacteria The first characterisation of an N-linked glycosylation in a bacterium was in the enteric 48 pathogen Campylobacter jejuni which now has one of the most studied of all prokaryotic 49 glycosylation pathways 7 . Genomic and proteomic studies have demonstrated that, PglB is 50 an oligosaccharyltransferase responsible for the covalent attachment of N-linked 51 glycan GalNAc-α1,4-GalNAc-α1,4-GalNAc-52 α1,3-Bac-β1; where GalNAc is N-acetylgalactosamine; Glc is glucose; diBacNAc is 2,4-53 diacetamido -2,4,6-trideoxyglucopyronose) to the asparagine residue in the acceptor 54 sequon D/E-X1-N-X2-S/T where X1 and X2 are any amino acid except proline 7 . In depth 55 studies on N-linked glycan diversity have revealed that there are 16 different glycans 56 present in Campylobacter genus. Surprisingly, the first two glycans (diBacNAc and 57 HexNAc) were conserved in all species 8, 9 . Whilst the role of N-linked glycan remains to be 58 elucidated, disruption of the N-linked glycosylation pathway resulted in pleotropic effects 59 such as decreased chicken colonisation 10 , reduced adherence to intestinal cells 11 as well 60 as impaired bacterial competence 12 . These studies did not ascertain the direct role of N-61 linked glycans in the C. jejuni glycoproteome. To address this, we sought to investigate the 62 biophysical role of N-linked glycosylation on a representative post translationally modified 63 glycoprotein. We demonstrate a critical role for glycosylation by focusing on a resistance-64 nodulation-division type (RND) multidrug efflux pump denoted Campylobacter multidrug 65 efflux; CmeABC. 66
67
CmeABC is a tripartite molecular assembly of glycoproteins, CmeB; an inner membrane 68 multidrug transport protein, CmeA; a periplasmic fusion protein and CmeC; an outer 69 membrane associated channel. The complex plays a key role in chicken colonization 13 , as 70 well as being responsible for multidrug resistance (MDR) 14 . Previously, we demonstrated 71 that disrupting pglB in C. jejuni impaired the efflux activity of CmeABC resulting in 72 significantly higher ethidium bromide accumulation when compared to the wildtype 73 (Abouelhadid S, et al submitted manuscript). The absence of glycosylation on the CmeABC 74 locus within C. jejuni was also shown to reduce resistance to four different antibiotic 75
classes. Here in, we show that the loss of N-linked glycans in CmeABC is the sole reason 76 for this phenotype and not a pleiotropic effect caused by pglB disruption. We also unravel 77 the intrinsic role of N-linked glycans in a) modulating global protein structure b) enhancing 78 glycosylated CmeA; g2CmeA thermostability and c) significantly slowing the unfolding rate 79 of g2CmeA. Finally, we evaluate the extrinsic role of N-linked glycans in the molecular 80 assembly of CmeABC to discern the difference in binding kinetics of CmeA variants to 81
CmeC. The study highlights the multifunctional role of N-linked glycans in enhancing 82 protein thermostability, stabilising protein complexes and the promotion of protein-83 protein interaction. Here we present a model N-linked glycosylation system with a 84 tractable phenotype to be used in studying glycan evolution, function and diversity. . Previously, we showed that the multidrug efflux pump is impaired in the 102 glycosylation deficient C. jejuni. This resulted in a significant increase in ethidium bromide 103 accumulation more than the parent strain and a reduction in antibiotics resistance 104 (Abouelhadid S, et al submitted manuscript). We hypothesise that this deficiency may be 105 due to assembly destabilisation as a consequence of glycosylation aberration. To address 106 this question, we sought to study the major multidrug efflux pump of C. jejuni, in a 107 glycosylation deficient CmeABC complex. We conducted the experiments in a C. jejuni 108 cmeD::cat r background strain in order to avoid the interaction of CmeDEF with CmeABC 109 that might mask the functional role of N-linked glycans. This parent strain was used to 110 construct a C. jejuni WTCmeABC strain and a C. jejuni glycosylation altered strain;g0CmeABC whereby, N->Q in each glycosylation sequon (D/E-X1-N-X2-S/T where X1 and X2 112 are any amino acids other than proline). Since cmeABC is an operon, we added a 6x His tag 113 at the C-terminal of CmeC to monitor changes in CmeABC expression. We then grew both 114 WTCmeABC and g0CmeABC strains to an OD600 =0.4-0.5, tetracycline was then added to 115 inhibit protein synthesis. CmeC levels in both strains were monitored for 2 hours. Our data 116
show no difference in CmeC expression in WTCmeABC and g0CmeABC strains Fig 1, A.  117 Once inserted in the outer membrane CmeC might be unreachable region to proteases. 118 Therefore, we conclude that N-linked glycans, in this case, do not protect CmeC from 119 native proteolytic degradation. We observed two bands in the WTCmeC (lanes 2, 4, 6, 8) 120 that migrated slower than the band corresponding to non-glycosylated CmeC in g0CmeC 121 (lanes 1, 3, 5, 7). Western blot analysis confirmed that the two bands observed in WTCmeC 122 lanes correspond to two glycospecies for the protein . Fig 1, suggested that glycans force the polypeptide chain to adopt a more extended 162 conformation through restricting residual structures formation in the unfolded state 23, 24 .
163
To investigate the role that N-linked glycans play in modulating the biophysical propertiesof CmeABC, we used circular dichroism (CD) spectroscopy. This allowed us to monitor the 165 secondary structure as well as the conformational changes upon thermal denaturation of 166 CmeA variants. Far-UV spectra for both g0CmeA and g2CmeA in 10 mM sodium phosphate, 167 75 mM sodium chloride, 10% glycerol buffer (pH 8) were collected at 20 °C. The spectrum 168 exhibited helical structure signature with two negative minima at 208 and 222 nm. It also 169 showed a positive maximum at 196 nm suggesting the presence of beta-sheets structure 170
Fig 3
Superimposed CD spectra exhibit g0CmeA spectrum, shown in black, was slightly red 171 shifted towards the β sheet. The CD spectra of both proteins were then analysed by 172 BESTSEL 25 for secondary structure content. Table 2 shows the secondary structure 173 content of g0CmeA and g2CmeA at room temperature. Our results show that N-linked 174 glycans confer subtle changes in protein global conformation. 175
Glycans enhances protein thermostability 176 177
It has been established that N-linked glycans play a role in stabilising glycoproteins 178 thermodynamically in eukarotes 3, 22 . The intrinsic role of N-linked glycans in stabilising 179
CmeA was investigated through analysing the CD spectra recorded for g0CmeA and g2CmeA proteins. The two populations exhibited different binding kinetics, notably, fast and slow 215 dissociation rates that contributed to weak and strong interactions, respectively 26 . We 216 employed a CM5 chip with g0CmeA and g2CmeA immobilised through amine coupling, 217 CmeC was then injected over CmeA variants surfaces in different concentrations. In our 218 model, g0CmeA and g2CmeA exhibited multiple events interaction with CmeC. These 219 interaction events can be attributed to a fast and a slow association and dissociation rates. 220 ). This difference in the kon rate indicates that g2CmeA possess more binding 226 pockets that allows slow yet high affinity interactions with CmeC compared to g0CmeA. 227
The equilibrium dissociation rate constants (KD) derived from the binding kinetics analysis 228 were 1.7e -8 (M) and 5e -9 (M) and g0CmeA and g2CmeA, respectively. 229 and with a greater number of sites bound. Similar to binding curves observed at pH 7.4, 232 g2CmeA showed a favourable slow association and dissociation binding curves than 233 g0CmeA. The number of sites for slow interaction were greater for g2CmeA contributing 234 to a modestly higher affinity for interaction with CmeC compared to a weaker affinity for 235
CmeC exhibited by g0CmeA. To confirm that variations in binding kinetics were not due to 236 differences in structural orientation between g0CmeA and g2CmeA, both proteins were 237 immobilised on NTA chip using C-terminal 6xHis tag, CmeC was then passed in different 238 concentrations. Binding kinetics indicated similar kon and koff for both CmeA variants, 239 although fewer sites were available Suppl 2. Interestingly, g2CmeA bound more CmeC than 240 g0CmeA, confirming the data seen with amine coupling. These results show a complex 241 binding pattern between CmeA variants and CmeC. They also suggest an extrinsic role for 242 N-linked glycans, exhibited in the variation in binding kinetics between g0CmeA andg2CmeA, where the glycosylated form of CmeA showed a greater proportion of higher 244 affinity interaction sites than its non-glycosylated counterpart. 245
Discussion 246
Whilst the role of glycosylation in eukaryotes has been thoroughly explored, a similar 247 depth of investigation is lacking in prokaryotes. The presence of different glycosylation 248 systems in prokaryotes has been regularly reported 2, 7, [11] [12] [13] . Some have described their 249 effect in virulence, adhesion and motility by creating genetic knock outs of the 250 glycosylation machinery 32, 33, [10] [11] [12] . Nonetheless, these reports have not provided in-depth 251 studies into the direct role that N-linked glycans exert on protein function. showed that g2CmeA seems to be responding to a rise in temperature via conformational 295 rearrangements at 2.4 o C ±0.1 lower than g0CmeA Fig 4, A. CD spectra recorded after 296 cooling showed that the structural rearrangements were reversible and the protein could 297 fold again, suggesting that protein fold/unfolding Tm1 and Tm2 are reversible for both of 298 the CmeA variants. Remarkably, the unfolding behaviour of g2CmeA at Tm3 was different 299 to g0CmeA at its correspondent Tm3 in the conformational reversibility assay. Time taken 300 to unfold g2CmeA was at least 5 times more than g0CmeA, thus indicating a 301 role played by N-linked glycans in conferring greater resistance to unfolding Fig 4, C and  302 
D.
We postulate that N-linked glycans stabilise g2CmeA through a reduction in the 303 unfolding rate in g2CmeA, this finding agrees with the observation that eukaryotic N-304 linked glycans stabilise the hCD2ad through slowing the unfolding rate of the protein 50-305
fold when compared to its non-glycosylated counterpart 2 .
306
Owing to the lack of subcellular compartments, the extrinsic role of prokaryotic N-linked 307 glycans in protein-protein interaction has been not fully appreciated. Despite the scarcity 308 of glycoproteomic data, few molecular assemblies have been reported to have at least one 309 of its component to be glycosylated 17, 31 . We demonstrate a potential extrinsic role of N-310 linked glycans in CmeA interaction with CmeC. In an orthologous multidrug efflux pump; 311 AcrAB-TolC, AcrA showed the presence of two populations, of the same protein, interacting 312 with different kinetics to TolC. The two populations contributed to a fast weak interaction 313 and slow strong interaction Fig 5, A 459  460  461  462  463  464  465  466  467  468  469  470  471  472  473  474  475  476   Table 2  477  478  479  480  481 Table 2 Secondary structure calculation of g0CmeA and g2CmeA variants. CD 487 units were converted to delta epsilon units and loaded to BESTSEL server. 488
Although the conformations of both proteins are structurally similar, there is a 489 subtle shift in the alpha helices and beta sheets ratios between both variants .  490   491  492  493  494  495  496  497  498  499  500  501  502  503  504  505  506  507  508  509  510  511  512  513  514  515  516  517  518   519  520  Fig 4   537  538  539  540  541  542  543  544  545  546 The nucleotide sequence of cmeD gene was commercially synthesized (Clonetech, 656 USA) to also carry a chloramphenicol resistant gene; cat was inserted in the middle 657 of cmeD to disrupt the gene. The DNA was then released by restriction digestion with 658
EcoRV and cloned in pJET1.2 -following manufacturer's instructions-to give pATN. 659
Cloning of cmeABC-aphA was achieved by the following; cmeABC locus was 660 amplified by primer FWDCmeA and primerREVCmeC with Phusion polymerase 661 (New England biolabs, UK) using C. jejuni 11168H genomic DNA as a template, 6Xhis 662 tag was added at the C-terminus of the CmeC to track its expression. The PCR 663 amplicon was cloned in pJET1.2 following the manufacture's instructions to give 664 pMH3 that was then cut by BamHI to introduce the kanamycin resistant gene aphA, 665 to be used as an antibiotic selection marker after homologous recombination in C. 666 jejuni 11168H to give pMHT. To add homologous recombination arms for cmeABC-667 aphA, pMH3 was cut by SaCII to ligate cj0364 at the 3' end of aphA to give 668 pMHTF. For g0cmeABC-aphA, each 669 asparagine in the non-canonical glycosylation sequon (D/E-X1-N-X2-S/T where X1 670 and X2 are any amino acid except proline) was altered to glutamine in-silico and 671 nucleotide sequence of g0cmeABC was synthesized by (Clonetech, USA) DNA was 672 then treated as above to generate pATKH. 673
To generate C. jejuni cmeD::cat, electroporation of pATN into C. jejuni 11168H was 674 carried out as previously described 10 . The transformants were selected on CBA 675 plates supplemented with 10 µg/ml chloramphenicol and the double cross over 676 event was confirmed by PCR, this strain was then used as parent strain to generate 677 other mutants. Plasmids pMHT and pATK were electroporated into C. jejuni 
Ethidium bromide accumulation assay 693 694
Bacterial cells were grown to mid log phase (OD 600 0.4-0.5). Cells were harvested, 695 washed and resuspended in 0.1M sodium phosphate buffer pH 7 (previously 696 incubated in the VAIN) to OD 600 0.2. Cells were then incubated in the VAIN for 15 697 mins at 37 o C o before a 100µl aliquot was withdrawn to indicate time zero. Ethidium 698 bromide (Sigma, UK) was added to final concentration 2 µg/ml and fluorescence was 699 measured at 530 nm excitation and 600 nm emission using a plate reader (Molecular 700 Devices M3 plate reader, USA). 701
Expression of CmeA and gCmeA 702 703
Protein expression was carried out in E. coli strains unless stated otherwise. CmeA 704 and CmeC were expressed in E. coli DH10B carrying pMH5 plasmid and pAT3, 705 respectively, whilst gCmeA was expressed in E. coli SDB1 carrying pGVXN114, pWA2 706 and pACYC(pgl). Initiating cultures were grown overnight in LB broth supplemented 707 with appropriate antibiotics at 37 o C under shaking condition. The following day, 10 708 ml of culture was withdrawn from the shake flask to inoculate 400 ml LB broth 709 supplemented with appropriate antibiotics. To achieve optimal glycosylation of 710 CmeA, PglB was expressed from pGVXN114 by the addition of 0.5 mM ITPG at OD 711 600 0.5-0.6. Cultures were incubated at 37 o C for 24 hours with shaking. Cultures 712 were centrifuged and cell pellets washed with binding buffer (300 mM NaCl, 50 mM 713 NaH2PO4 with 25mM imidazole) and passed twice through a high pressure cell 714 homogeniser (Stanstead works, UK). Cell debris was removed by centrifugation at 715 20,000 xg for 45 minutes. Supernatant was collected and incubated with 0.2 ml Ni-716 NTA for 1 hour at 4 o C then washed with 50 ml binding buffer and eluted four times 717 in 0.5 ml elution buffer (300 mM NaCl, 50 mM NaH2PO4 with 250mM imidazole). 718
Cloning and expression of CmeC 719 720
To express CmeC in E. coli, cmeC lacking signal peptide sequence was amplified by 721 PCR with CmeCFwd1 and CmeCRev using C. jejuni 11168H genomic DNA as a 722 template. The amplicon was then cut by NheI and SalI and cloned into pEC415 723 downstream of the DsbA signal peptide sequence to give pCMECDSBA. E. coli 724 carrying pCMECDSBA was grown in LB media supplemented with ampicillin (100 725 µg/ml) overnight at 37 o C under shaking condition. On the following day, 10 ml were 726 withdrawn from the overnight culture to inoculate 400 ml LB media. Cells were 727 grown to OD 600 0.5-0.6 and 0.2% L-arabinose was added to induce the expression 728 of CmeC. Cultures were incubated at 37 o C for 24 hours with shaking at 180 rpm. 729
Cultures were centrifuged and cell pellets washed with binding buffer (300 mM NaCl, 730 50 mM NaH2PO4 with 25mM imidazole) and passed twice through cell homogeniser 731 (Stanstead works, UK). Cells debris was removed by centrifugation at 20,000 xg for 732 45 minutes and then collected and incubated in binding buffer with 2 % DDM for 3 733 hours at 4 o C. The mixture was then centrifuged at 15,000 xg for 10 minutes. The 734 supernatant was collected, diluted with binding buffer and incubated with 0.2 ml 735
Ni-NTA for 1 hour at 4 o C then washed with 50 ml binding buffer and eluted four 736 times in 0.5 ml elution buffer (300 mM NaCl, 50 mM NaH2PO4 with 250mM 737 imidazole). 738
CD Spectroscopy 739 740
All CD spectra of gCmeA and CmeA were acquired in 0.5mm rectangular cell 741 pathlength using Chirascan spectrometer (Applied Biophysics, UK) equipped with 742 Quantum NorthWest TC125 Peltier unit. Temperature dependent confirmation 743 changes were monitored at wavelength 260-195nm for gCmeA (0.2 mg/ml) and 744 CmeA (0.2 mg/ml) in 10 mM Sodium phosphate, 75 mM Sodium chloride, 10 % 745 glycerol buffer (pH=8.0) during stepwise increase in temperature from 6 o C to 94 o
C. 746
Temperatures were measured directly with a thermocouple probe in the sampleAmersham). Blank flow cell controls were subtracted. The kd was defined between 10s after 778 the end of the sample injection and 300 sec later.
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